Compare MCW & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCW | NNNN |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | 2025 |
| Metric | MCW | NNNN |
|---|---|---|
| Price | $5.75 | $31.10 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $7.68 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 30.0K |
| Earning Date | 10-29-2025 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.84 | N/A |
| EPS | ★ 0.27 | 0.06 |
| Revenue | ★ $1,041,660,000.00 | $8,185,146.00 |
| Revenue This Year | $6.86 | N/A |
| Revenue Next Year | $6.87 | N/A |
| P/E Ratio | ★ $21.23 | $598.39 |
| Revenue Growth | 6.98 | ★ 21.95 |
| 52 Week Low | $4.61 | $5.18 |
| 52 Week High | $8.60 | $55.65 |
| Indicator | MCW | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 66.32 | 53.55 |
| Support Level | $5.59 | $26.06 |
| Resistance Level | $5.82 | $36.12 |
| Average True Range (ATR) | 0.15 | 6.11 |
| MACD | 0.05 | -0.28 |
| Stochastic Oscillator | 90.12 | 29.57 |
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.